SCHEMBL13033247

SCHEMBL13033247

NCCNCCN(CCN)CCNCCN

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.56
CYP2C9 P11712 2/20 0.56
CA12 O43570 5/20 0.56
CA6 P23280 5/20 0.56
CA7 P43166 5/20 0.56
CA9 Q16790 5/20 0.56
CA14 Q9ULX7 5/20 0.56
CA5B Q9Y2D0 5/20 0.56
MEN1 O00255 2/20 0.56
RECQL P46063 2/20 0.56
KMT2A Q03164 2/20 0.56
CA2 P00918 4/20 0.53
CA4 P22748 4/20 0.53
CA5A P35218 4/20 0.53
TDP1 Q9NUW8 3/20 0.53
LMNA P02545 3/20 0.53
CA3 P07451 3/20 0.53
ALOX15 P16050 3/20 0.53
CA1 P00915 2/20 0.53
ALDH1A1 P00352 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL600153 1.00 CYP2C19 (0.56) CYP2C19CYP2C9CA12CA6CA7
SCHEMBL9064147 1.00 CYP2C19 (0.56) CYP2C19CYP2C9CA12CA6CA7
SCHEMBL23489527 1.00 CYP2C19 (0.56) CYP2C19CYP2C9CA12CA6CA7
SCHEMBL13330251 1.00 CYP2C19 (0.56) CYP2C19CYP2C9CA12CA6CA7
SCHEMBL23489712 0.97 CA12 (0.58) CYP2C19CYP2C9CA12CA6CA7
SCHEMBL23489642 0.97 CA12 (0.58) CYP2C19CYP2C9CA12CA6CA7
SCHEMBL23489564 0.97 CA12 (0.58) CYP2C19CYP2C9CA12CA6CA7
SCHEMBL23489526 0.97 CA12 (0.58) CYP2C19CYP2C9CA12CA6CA7
SCHEMBL23489538 0.97 CA12 (0.58) CYP2C19CYP2C9CA12CA6CA7
SCHEMBL23489816 0.97 CA12 (0.58) CYP2C19CYP2C9CA12CA6CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2714611-B1 FORMALDEHYDE-FREE SIZING COMPOSITION FOR FIBRES, IN PARTICULAR MINERAL FIBRES, AND RESULTING PRODUCTS SAINT GOBAIN ISOVER (FR) 2020-05-20 EP claimed
WO-2012168621-A1 FORMALDEHYDE-FREE SIZING COMPOSITION FOR FIBRES, IN PARTICULAR MINERAL FIBRES, AND RESULTING PRODUCTS. SAINT-GOBAIN ISOVER (FR) 2012-12-13 WO claimed
EP-4644506-A1 HEAVY METAL TREATMENT AGENT, AND METHOD FOR TREATING WASTEWATER AND INCINERATION ASH USING SAME Miyoshi Oil & Fat Co., Ltd. (JP) 2025-11-05 EP disclosed
EP-4365258-A1 HEAVY METAL TREATMENT AGENT, AND METHOD FOR TREATING INCINERATED ASH AND WASTEWATER USING SAME Miyoshi Oil & Fat Co., Ltd. (JP) 2024-05-08 EP disclosed
US-11814761-B2 Process for producing mineral wool SAINT-GOBAIN ISOVER (FR) 2023-11-14 US disclosed
WO-2023204222-A1 AMINE COMPOSITION FOR CARBON DIOXIDE SEPARATION USE 東ソー株式会社 2023-10-26 WO disclosed
EP-3724142-B1 PROCESS FOR PRODUCING MINERAL WOOL SAINT GOBAIN ISOVER (FR) 2023-10-11 EP disclosed
US-20230257511-A1 EPOXY-AMINE ADDUCT EVONIK OPERATIONS GMBH (DE) 2023-08-17 US disclosed
WO-2022006874-A1 Epoxy-amine adduct EVONIK OPERATIONS GMBH (DE) 2022-01-13 WO disclosed
WO-2021109317-A1 POLYCATIONIC POLYSACCHARIDE AND APPLICATION THEREOF 南京大学 2021-06-10 WO disclosed
EP-3724142-A1 PROCESS FOR PRODUCING MINERAL WOOL SAINT-GOBAIN ISOVER (FR) 2020-10-21 EP disclosed
US-8287910-B2 Polymeric micelles for polynucleotide encapsulation INTEZYNE TECHNOLOGIES, INC. (US) 2012-10-16 US disclosed
US-8287910-B2 Polymeric micelles for polynucleotide encapsulation INTEZYNE TECHNOLOGIES, INC. (US) 2012-10-16 US disclosed
US-20100292432-A1 POLYMERS FOR POLYNUCLEOTIDE ENCAPSULATION INTEZYNE TECHNOLOGIES, INCORPORATED (US) 2010-11-18 US disclosed
WO-2010127159-A2 POLYMERIC MICELLES FOR POLYNUCLEOTIDE ENCAPSULATION INTEZYNE TECHNOLOGIES, INCORPORATED (US) 2010-11-04 WO disclosed
WO-2010127154-A1 POLYMERS FOR POLYNUCLEOTIDE ENCAPSULATION INTEZYNE TECHNOLOGIES, INCORPORATED (US) 2010-11-04 WO disclosed
US-20100278927-A1 POLYMERIC MICELLES FOR POLYNUCLEOTIDE ENCAPSULATION INTEZYNE TECHNOLOGIES, INCORPORATED (US) 2010-11-04 US disclosed
US-20100278927-A1 POLYMERIC MICELLES FOR POLYNUCLEOTIDE ENCAPSULATION INTEZYNE TECHNOLOGIES, INCORPORATED (US) 2010-11-04 US disclosed
EP-2114860-B1 PRODUCTION METHOD FOR ETHYLENEAMINE MIXTURES BASF SE (DE) 2010-09-29 EP disclosed
WO-2008104552-A1 PRODUCTION METHOD FOR ETHYLENEAMINE MIXTURES BASF SE (DE) 2008-09-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100278927-A1 POLYMERIC MICELLES FOR POLYNUCLEOTIDE ENCAPSULATION NCL, POLN, CHMP4B CYP2C19 4867/4885CYP2C9 4854/4885CA12 3196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.